Human Papillomavirus-Related Cervical Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (NCT05237947)	National Cancer Institute (NCI)	2022-03-01
Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial (NCT03728881)	National Cancer Institute (NCI)	2019-04-01
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer (NCT03634267)	M.D. Anderson Cancer Center	2018-08-03
Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study (NCT03180034)	National Cancer Institute (NCI)	2017-11-29
Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (NCT02774538)	Institut de Cancérologie de Lorraine	2016-05-11
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls (NCT00867464)	National Cancer Institute (NCI)	2009-03-30

Every clearance here is in the API, with alerts when new ones post.